Work

Therapeutic modalities of deferiprone in Parkinson's disease:SKY and EMBARK studies.

Year: 2025

Type: article

Source: LillOA (Université de Lille (University Of Lille))

Authors: Devos, D. (David), Rascol, O. (O.), Meissner, W.G. (W. G.), Foubert-Samier, A. (A.), Lewis, S. (S.), Tranchant, C. (C.), Anheim, M. (M.), Maltête, D. (D.), Remy, P. (P.), Eggert, K. (K.), Pape, H. (H.), Geny, C. (C.), Couratier, P. (P.), Carroll, C. (C.), Sheridan, R. (R.), Burn, D. (D.), Pavese, N. (N.), Raw, J. (J.), Berg, D. (D.), Suchowersky, O. (O.), Kalia, L.V. (L. V.), Evans, A. (A.), Drapier, S. (S.), Danaila, T. (T.), Schnitzler, A. (A.), Corvol, J.C. (J. C.), Defer, G. (G.), Temin, N.T. (N. T.), Fradette, C. (C.), Tricta, F. (F.), Moreau, C. (caroline)

Language: English

Topic: Parkinson's Disease Mechanisms and Treatments

Subfield: Neurology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7074224935

FWCI:

Cites:

Cited by:

Related to: